Journal Article Summary
The article investigates the effects of different micronutrient supplementation strategies during pregnancy on adverse birth outcomes in Botswana. This topic is significant because adverse birth outcomes, such as stillbirth and preterm birth, are prevalent in sub-Saharan Africa, particularly among women with HIV. Current World Health Organization (WHO) guidelines recommend iron and folic acid supplementation, but there is ongoing debate about the effectiveness of multiple micronutrient supplementation (MMS), which includes a broader range of vitamins and minerals.
The study analyzed data from over 96,000 women who gave birth in Botswana between 2014 and 2020, comparing four supplementation strategies: folic acid only, iron only, iron and folic acid (IFAS), and MMS. The findings revealed that women who received MMS had lower risks of preterm birth and low birthweight compared to those who received IFAS. Additionally, women who took only iron or folic acid had higher risks of adverse outcomes compared to those on IFAS, particularly among women with HIV and those aged 35 and older.
However, the study has limitations, including potential confounding factors that could affect the results, such as the timing of supplementation initiation and adherence issues. It is essential for readers to discuss these findings with healthcare professionals, especially regarding their own supplementation needs during pregnancy. The study highlights the importance of improving access to micronutrient supplementation to enhance maternal and infant health outcomes, particularly in populations at higher risk for adverse birth outcomes.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Caniglia Ellen C, Zash Rebecca, Swanson Sonja A, Smith Emily, Sudfeld Christopher, Finkelstein Julia L, Diseko Modiegi, Mayondi Gloria, et al.. Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in Botswana. The Lancet. Global health 2022. DOI: 10.1016/S2214-109X(22)00126-7. PMID: 35561720. PMCID: PMC9309424.
Featured Pill Pals Product
Folic Acid 1 mg Tablets --- Generic For Folvite --- Modavar
Folic Acid 1 mg Tablets — Generic For Folvite — Modavar is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
